Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy

Published:2024-02 Issue:2 Volume:118 Page:404-414
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Simone Charles B.^ORCID,Serebrenik Artur A.^ORCID,Gore Elizabeth M.,Mohindra Pranshu,Brown Stephen L.,Wang Ding,Chetty Indrin J.,Vujaskovic Zeljko,Menon Smitha,Thompson Jonathan,Fine Gil,Kaytor Michael D.,Movsas Benjamin

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference39 articles.

1. National Cancer Institute. Surveillance, Epidemiology and End Results Program. Available at: www.seer.cancer.gov. Accessed December 26, 2022.

2. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016

3. Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer;Spina;Intern Med J,2013

4. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis;Palma;Int J Radiat Oncol Biol Phys,2013

5. Thoracic radiation normal tissue injury;Simone;Semin Radiat Oncol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP